PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
01-Jun-2020 Orgenesis to collaborate with The Edith Wolfson Medical Center to conduct clinical study using Orgenesis’ proprietary POCare technologies for the generation and expansion of Tumor Infiltrating Lymphocytes Orgenesis Inc
29-May-2020 Chi-Med Announces NDA Acceptance in China for Savolitinib in the Treatment of Non-Small Cell Lung Cancer with MET Exon 14 Skipping Mutations Chi-Med
29-May-2020 New number of shares and votes in Moberg Pharma AB (publ) Moberg Pharma
29-May-2020 Santhera Provides Update on the Ongoing Regulatory Review of Puldysa® (Idebenone) by the CHMP in Duchenne Muscular Dystrophy (DMD) Santhera Pharmaceuticals
29-May-2020 Interim analysis presented at the American Society of Clinical Oncology (ASCO) Annual Meeting London’s Global University
29-May-2020 COVID-19 vaccine development: new guidelines for ethical approach to infecting trial volunteers University of Warwick
29-May-2020 First patient dosed in Achilles’ Phase I/II study in melanoma Syncona
28-May-2020 Peli BioThermal Expands Global Rental Network in Incheon, South Korea Peli BioThermal
28-May-2020 Sanofi intends to sell its equity investment in Regeneron; confirms no change to ongoing collaboration Sanofi
28-May-2020 Nordic Nanovector ASA: Results for the First Quarter 2020 Nordic Nanovector
28-May-2020 Chi-Med and BeiGene Enter into Clinical Collaboration to Evaluate Combinations of Surufatinib and Fruquintinib with Tislelizumab Hutchison China MediTech Limited
28-May-2020 Sanofi intends to sell its equity investment in Regeneron; confirms no change to ongoing collaboration Sanofi
28-May-2020 COVID-19: RSC offers grants for scientists working from home Royal Society of Chemistry
28-May-2020 Inivata Announces Strategic Collaboration and Investment from NeoGenomics NeoGenomics, Inc.
28-May-2020 Cambridge Innovation Capital portfolio company Inivata announces strategic collaboration and investment from NeoGenomics Cambridge Innovation Capital
28-May-2020 Gavi: Partnering to protect future generations from infectious diseases ABPI
28-May-2020 Roche’s Tecentriq gains first-line approval in NSCLC but Keytruda reigns supreme, says GlobalData Roche
28-May-2020 Dupixent® (dupilumab) eosinophilic esophagitis trial meets both co-primary endpoints Regeneron
28-May-2020 Immunocore announces dosing of first patient with fourth ImmTAC® Immunocore
28-May-2020 Vectura provides AGM trading update and reiterates 2020 guidance Vectura